LEARNING OBJECTIVES

• Evaluate the indications and risks of peripheral vascular disease and critical limb ischemia.
• Identify a treatment option algorithm and address complications of peripheral vascular disease and critical limb ischemia.
• Interpret biomarkers, genome, and genetic determinants of patients with cardiovascular disease
• Demonstrate appropriate pharmacologic management in the care of patients with cardiovascular disease.
• Define the basic principles and management of venous disease and foot ulcers.
• Identify the indications, risks, treatment options, and complications of arch, descending, thoracoabdominal and abdominal aneurysms and dissections.
• Recognize the current treatment options and management of acute/chronic, symptomatic/asymptomatic, and complicated/uncomplicated aortic disease.
• Analyze the latest trials for aortic, peripheral vascular disease venous and foot ulcers.
• Formulate a treatment algorithm for carotid disease.
• Discuss the pros and cons of new and established strategies for acute and chronic DVT treatment, what still works, what might work and what doesn’t work based on evidence.

ACCREDITATION

Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Arizona Medical Association (ArMA) through the Joint Providership of HonorHealth and Give For Good Foundation, Inc. HonorHealth is accredited by ArMA to provide continuing medical education for Physicians.

Credit Statement: HonorHealth designates this live activity for a maximum of 20 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

TED 2024 will feature a series of informative lectures by thought leaders in the field, hands-on training, live cases with active discussions along with debates about current strategies, controversial topics, and the discussion of transition of care to the Office Based Lab and Ambulatory Surgery Center.

For more information please visit the official event page.